Press Releases

Revolutionizing Metabolomics: Creative Proteomics Unveils LC-MS/MS Untargeted Metabolomics Service

Innovative SILAC-Based Proteomics Analysis Service Launched by Creative Proteomics

Creative Proteomics Introduces Methionine Cycle Analysis Service for Metabolomics Research

BioIVT Expands its Biospecimen Portfolio in Support of Neuroscience Research

BioIVT will be available to discuss its newly expanded, comprehensive portfolio of neuro-related disease and TruNormal® biospecimens at Neuroscience 2023.

Fapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China

Fapon entered into a strategic cooperation agreement with two Swiss biotech companies LASCCO SA and Abionic SA, that granted Fapon an exclusive license to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. This strategic partnership will enable Fapon to engage in the research, development, manufacturing, and commercialization of PSP raw materials and chemiluminescent immunoassay (CLIA)-based reagent solutions within the Chinese market.

Elemental, Ions and Water (Karl Fischer) Standards Make Analytical Testing More Accurate and Easier

Maximizing Therapeutic Potential: CD Formulation's Versatile Drug Delivery Systems Advance Pharmacokinetics and Pharmacodynamics

Proscia Achieves ISO 27001 Security Certification

Compliance with global information security management standard strengthens customer trust

Lifeasible Established a Chrysanthemum Genetic Transformation Platform

Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox

Securing the Integrity of Microneedle Structure Design and Optimization: CD Formulation's Performance Testing Approach

Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use

Creative BioMart Provides a Wide Range of Biomarker Proteins for Research Use

Creative Biolabs Unveils ADC Services, Igniting Excitement in the Biotech Industry

Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services.

Creative Enzymes Unveils Advanced Substrate, Inhibitor, and Ligand Screening Services

Creative Enzymes Unveils the Creative SuperCut Series: Redefining Precision in Molecular Biology

Empowering Research Excellence: Alfa Chemistry's THEIC, D-Pantethine, and Methoxytriethyleneoxypropyltrimethoxysilane at the Forefront

PathAI Diagnostics Unveils World’s First AI-Assisted Laboratory Developed Test for MASLD and MASH

PathAI Diagnostics' test allows for the histologic scoring and staging of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). It will be announced at the American College of Gastroenterology 2023 Meeting October 20-25 in Vancouver, Canada.

Censinet and First Health Advisory Partner to Deliver Comprehensive Cyber Risk Assurance to Health Sector

Partnership Enables Healthcare Organizations to Leverage Unique Risk Advisory Services and Purpose-Built Workflow Automation to Maximize Cyber Risk Reduction

CD Formulation's Scientists Share A Holistic Approach on How to Prepare Drug Microcapsules